written on 16.05.2014

Sweden politely excoriates Pfizer over megamerger with AstraZeneca


As the May 26 deadline for Pfizer to sweeten its $106 billion offer for AstraZeneca draws closer, a bevy of Swedish officials are now echoing the British government's concern that the deal will be bad for European business.

Latest Reports